MVA congratulates professor Hindrik Mulder and Lund University with the prestigious Novo Nordisk Foundation Lecture Prize

Professor Hindrik Mulder’s research on islet cells and his commitment to the scientific community have been recognized as he receives the 2024 Novo Nordisk Foundation Lecture Prize, which comes with a DKK 600,000 award. “Swedish-Danish Medicon Valley Alliance would like to congratulate both professor Hindrik Mulder and Lund University with the prestigious award. It testifies to both the high quality of Medicon Valley based life science research, the growing awareness of the synergies between Danish and Swedish life science and the potential for further collaboration also highlighted at the Danish Kings and Queens recent state visit to Sweden,” says MVA CEO, Anette Steenberg. The Novo Nordisk Foundation Lecture Prize The Novo Nordisk Foundation Lecture Prize, established in 1979, is awarded annually by the Foundation and the Scandinavian Society for the Study of Diabetes (SSSD) to recognize a Nordic scientist’s outstanding contribution within research or treatment related to diabetes. It is accompanied by an award of DKK 500,000 for research and a personal award of DKK 100,000. Mulder was selected as this year’s recipient by a committee comprising members of the Novo Nordisk Foundation’s Committee on Endocrinology and Metabolism – including former Chair, Professor Anna Krook from the Karolinska Institute, Sweden – and Professor Bjørn Olav Åsvold, from the HUNT Research Centre, Norway, and Chair of the SSSD. “Hindrik is a worthy recipient of this year’s Lecture Prize,” says Professor Lena Eliasson, Department of Clinical Sciences, Lund University Diabetes Center, Sweden and newly appointed Chair of the Committee on Endocrinology and Metabolism. “He is incredibly generous, knowledgeable, and a really good teacher, in addition to being an excellent scientist in islet research. Among his contributions is the functional aspects on a cellular level of several diabetes-associated genes, which has increased our current understanding of this disease. In addition, Hindrik is an active contributor to the diabetes research community, both at the national and European level.” Read full article in Nordic Life Science News